United States T-Cell Immunotherapy Market Report & Forecast 2021-2027

United States T-Cell Immunotherapy Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States T-Cell Immunotherapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States T-Cell Immunotherapy Overall Market Size
2.1 United States T-Cell Immunotherapy Market Size: 2021 VS 2027
2.2 United States T-Cell Immunotherapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Immunotherapy Players in United States Market
3.2 Top United States T-Cell Immunotherapy Companies Ranked by Revenue
3.3 United States T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in United States Market, by Revenue in 2020
3.5 Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in United States Market
3.6.1 List of Tier 1 T-Cell Immunotherapy Companies in United States
3.6.2 List of Tier 2 and Tier 3 T-Cell Immunotherapy Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States T-Cell Immunotherapy Market Size Markets, 2021 & 2027
4.1.2 CAR-T
4.1.3 TCR
4.1.4 TIL Therapies
4.2 By Type - United States T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - United States T-Cell Immunotherapy Revenue, 2016-2021
4.2.2 By Type - United States T-Cell Immunotherapy Revenue, 2022-2027
4.2.3 By Type - United States T-Cell Immunotherapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States T-Cell Immunotherapy Market Size, 2021 & 2027
5.1.2 Stomach Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophagus Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - United States T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - United States T-Cell Immunotherapy Revenue, 2016-2021
5.2.2 By Application - United States T-Cell Immunotherapy Revenue, 2022-2027
5.2.3 By Application - United States T-Cell Immunotherapy Revenue Market Share, 2016-2027
6 T-Cell Immunotherapy Companies Profiles
6.1 Adaptimmune
6.1.1 Adaptimmune Company Details
6.1.2 Adaptimmune Business Overview
6.1.3 Adaptimmune T-Cell Immunotherapy Introduction
6.1.4 Adaptimmune T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.1.5 Adaptimmune Recent Developments
6.2 Altor Bioscience Corporation
6.2.1 Altor Bioscience Corporation Company Details
6.2.2 Altor Bioscience Corporation Business Overview
6.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
6.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.2.5 Altor Bioscience Corporation Recent Developments
6.3 Cellectis
6.3.1 Cellectis Company Details
6.3.2 Cellectis Business Overview
6.3.3 Cellectis T-Cell Immunotherapy Introduction
6.3.4 Cellectis T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.3.5 Cellectis Recent Developments
6.4 Juno Therapeutics
6.4.1 Juno Therapeutics Company Details
6.4.2 Juno Therapeutics Business Overview
6.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
6.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.4.5 Juno Therapeutics Recent Developments
6.5 Kite Pharma
6.5.1 Kite Pharma Company Details
6.5.2 Kite Pharma Business Overview
6.5.3 Kite Pharma T-Cell Immunotherapy Introduction
6.5.4 Kite Pharma T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.5.5 Kite Pharma Recent Developments
6.6 Novartis
6.6.1 Novartis Company Details
6.6.2 Novartis Business Overview
6.6.3 Novartis T-Cell Immunotherapy Introduction
6.6.4 Novartis T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.6.5 Novartis Recent Developments
6.7 Takara Bio
6.7.1 Takara Bio Company Details
6.7.2 Takara Bio Business Overview
6.7.3 Takara Bio T-Cell Immunotherapy Introduction
6.7.4 Takara Bio T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.7.5 Takara Bio Recent Developments
6.8 Unum Therapeutics
6.8.1 Unum Therapeutics Company Details
6.8.2 Unum Therapeutics Business Overview
6.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
6.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in United States Market (2016-2021)
6.8.5 Unum Therapeutics Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. T-Cell Immunotherapy Market Opportunities & Trends in United States Market
Table 2. T-Cell Immunotherapy Market Drivers in United States Market
Table 3. T-Cell Immunotherapy Market Restraints in United States Market
Table 4. Key Players of T-Cell Immunotherapy in United States Market
Table 5. Top T-Cell Immunotherapy Players in United States Market, Ranking by Revenue (2019)
Table 6. United States T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States T-Cell Immunotherapy Revenue Share by Companies, 2016-2021
Table 8. Companies T-Cell Immunotherapy Product Type
Table 9. List of Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States T-Cell Immunotherapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States T-Cell Immunotherapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States T-Cell Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States T-Cell Immunotherapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States T-Cell Immunotherapy Revenue (US$, Mn), 2022-2027
Table 17. Adaptimmune Company Details
Table 18. Adaptimmune Business Overview
Table 19. Adaptimmune T-Cell Immunotherapy Product
Table 20. Adaptimmune T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Adaptimmune Recent Developments
Table 22. Altor Bioscience Corporation Company Details
Table 23. Altor Bioscience Corporation Business Overview
Table 24. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 25. Altor Bioscience Corporation T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Altor Bioscience Corporation Recent Developments
Table 27. Cellectis Company Details
Table 28. Cellectis Business Overview
Table 29. Cellectis T-Cell Immunotherapy Product
Table 30. Cellectis T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Cellectis Recent Developments
Table 32. Juno Therapeutics Company Details
Table 33. Juno Therapeutics Business Overview
Table 34. Juno Therapeutics T-Cell Immunotherapy Product
Table 35. Juno Therapeutics T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Juno Therapeutics Recent Developments
Table 37. Kite Pharma Company Details
Table 38. Kite Pharma Business Overview
Table 39. Kite Pharma T-Cell Immunotherapy Product
Table 40. Kite Pharma T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Kite Pharma Recent Developments
Table 42. Novartis Company Details
Table 43. Novartis Business Overview
Table 44. Novartis T-Cell Immunotherapy Product
Table 45. Novartis T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Novartis Recent Developments
Table 47. Takara Bio Company Details
Table 48. Takara Bio Business Overview
Table 49. Takara Bio T-Cell Immunotherapy Product
Table 50. Takara Bio T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Takara Bio Recent Developments
Table 52. Unum Therapeutics Company Details
Table 53. Unum Therapeutics Business Overview
Table 54. Unum Therapeutics T-Cell Immunotherapy Product
Table 55. Unum Therapeutics T-Cell Immunotherapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Unum Therapeutics Recent Developments
List of Figures
Figure 1. T-Cell Immunotherapy Segment by Type
Figure 2. T-Cell Immunotherapy Segment by Application
Figure 3. United States T-Cell Immunotherapy Market Overview: 2020
Figure 4. United States T-Cell Immunotherapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States T-Cell Immunotherapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2020
Figure 7. By Type - United States T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 8. By Application - United States T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 9. Adaptimmune T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Altor Bioscience Corporation T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Cellectis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Juno Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Kite Pharma T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Novartis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Takara Bio T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Unum Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs